Relationship between gene expression and lung function in Idiopathic Interstitial Pneumonias.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4621862)

Published in BMC Genomics on October 26, 2015

Authors

Mark P Steele1, Leah G Luna2, Christopher D Coldren3, Elissa Murphy3, Corinne E Hennessy3, David Heinz3, Christopher M Evans3, Steve Groshong3,4, Carlyne Cool3,4, Gregory P Cosgrove3,4, Kevin K Brown3,4, Tasha E Fingerlin2,5, Marvin I Schwarz3, David A Schwartz2,3,4, Ivana V Yang6,7,8

Author Affiliations

1: Department of Medicine, Vanderbilt University, Nashville, TN, USA.
2: Center for Genes, Environment and Health, National Jewish Health, Denver, CO, USA.
3: Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
4: Department of Medicine, National Jewish Health, Denver, CO, USA.
5: Department of Biostatistics and Bioinformatics, Colorado School of Public Health, Aurora, CO, USA.
6: Center for Genes, Environment and Health, National Jewish Health, Denver, CO, USA. ivana.yang@ucdenver.edu.
7: Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA. ivana.yang@ucdenver.edu.
8: Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA. ivana.yang@ucdenver.edu.

Articles cited by this

Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res (2003) 52.74

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med (2002) 19.02

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med (2000) 12.71

Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med (2001) 4.39

Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med (2005) 4.25

Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med (2001) 4.01

Gene expression profiling of familial and sporadic interstitial pneumonia. Am J Respir Crit Care Med (2006) 3.32

Expression profiling--best practices for data generation and interpretation in clinical trials. Nat Rev Genet (2004) 2.91

Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β. Am J Respir Crit Care Med (2012) 2.68

The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (2000) 2.63

Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs? PLoS Med (2008) 2.41

Assessment of health-related quality of life in patients with interstitial lung disease. Chest (1999) 2.21

A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am J Pathol (2008) 2.17

A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (1999) 2.08

Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. PLoS One (2007) 1.88

The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. PLoS One (2013) 1.78

Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis. Thorax (2013) 1.77

Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF). PLoS One (2009) 1.56

ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Eur Respir J (2002) 1.52

The molecular basis of leukocyte recruitment and its deficiencies. Mol Immunol (2012) 1.30

NetworkAnalyst--integrative approaches for protein-protein interaction network analysis and visual exploration. Nucleic Acids Res (2014) 1.29

The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice. J Clin Invest (2010) 1.27

GEST: a gene expression search tool based on a novel Bayesian similarity metric. Bioinformatics (2001) 1.15

An expression atlas of human primary cells: inference of gene function from coexpression networks. BMC Genomics (2013) 1.11

Hypoxia-inducible factor-1α mediates TGF-β-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2011) 1.11

The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis. PLoS One (2012) 1.07

A novel developmentally regulated gene in lung mesenchyme: homology to a tumor-derived trypsin inhibitor. Am J Physiol (1999) 1.04

Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis. Biomark Insights (2012) 0.99

E- and P-selectins synergistically inhibit bleomycin-induced pulmonary fibrosis. Am J Pathol (2006) 0.90

Functional variants in NFKBIE and RTKN2 involved in activation of the NF-κB pathway are associated with rheumatoid arthritis in Japanese. PLoS Genet (2012) 0.89

Identification and characterization of a lymphocytic Rho-GTPase effector: rhotekin-2. Biochem Biophys Res Commun (2004) 0.85

Respiratory bronchiolitis-associated interstitial lung disease. Semin Respir Crit Care Med (2003) 0.81

Increased level of soluble E-selectin in the serum from patients with idiopathic pulmonary fibrosis. Inflammation (2004) 0.78